Chinese state-owned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID-19 vaccine in Abu Dhabi using up to 15,000 volunteers, the government in the capital of the United Arab Emirates said on Thursday.
FILE PHOTO: The company logo of Sinopharm Group Co Ltd is displayed at a news conference on the company's annual results in Hong Kong, China March 29, 2016. REUTERS/Bobby Yip/File Photo
No COVID-19 vaccine has yet been approved for commercial use. According to a WHO summary of the state of vaccine development for COVID-19, there are 23 potential vaccines in human trials, with three of them in or starting large-scale late stage, or Phase III, trials to test efficacy. Sinopharm chose the United Arab Emirates because around 200 different nationalities reside there and it has a focus on medical research and fighting the pandemic, Koshy said.
China has been looking overseas to trial potential vaccines because of a lack of new patients at home. China’s Sinovac Biotech is conducting Phase III trials of a vaccine in Brazil.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Early-stage trial data on AstraZeneca COVID-19 vaccine due July 20 - LancetThe Lancet medical journal said on Wednesday it will publish keenly-awaited phase 1 clinical trial data on a potential COVID-19 vaccine being developed by Astrazeneca and Oxford University on Monday.
Weiterlesen »
Moderna expects to start late-stage COVID-19 vaccine trial on July 27Moderna Inc said on Tuesday it plans to start a late stage clinical trial for its COVID-19 vaccine candidate on or around July 27, according to its listing for the phase 3 study at clinicaltrials.gov.
Weiterlesen »
Early-stage trial data on AstraZeneca COVID-19 vaccine due Monday - LancetEarly-stage human trial data on a vaccine being developed by AstraZeneca and Oxford University will be published on July 20, The Lancet medical journal said on Wednesday.
Weiterlesen »
Potential COVID-19 vaccine shows promise in early trial'It is good news that it's not bad news,' infectious disease expert Dr. Michael Osterholm says about promising results from Moderna's first COVID-19 vaccine trial. 'But remember, we're in the first 100 yards of a marathon.'
Weiterlesen »
COVID-19 vaccine: Early Oxford trial data to be published next weekThe World Health Organization's chief scientist said in June that the vaccine was probably the most advanced in terms of development.
Weiterlesen »